Corporate Profile | About Us

Company Name	TSD Japan, Inc.
Date Established	July 1, 2005
Capital Stock	32,900,000 yen
Main Business	1. Partnering 1) In-license drug candidates from domestic/foreign bio-venture companies and pharmaceutical companies 2) Conduct pre-clinical study based on development strategy/plan for drug candidates, and promote partnering with pharmaceutical companies in Japan by adding values to compounds. 2. Comprehensive Support for Clinical Studies 1) Being entrusted with clinical studies comprehensively from design of clinical development to preparation and application for NDA, utilizing our own clinical development function. 2) Support clinical studies and dispatch CRAs as a CRO. 3. Consulting for Clinical Development 1) Offer strategic consultation throughout the drug development process which covers development planning, NDA, pricing and marketing. 2) Assist with planning and managing individual non-clinical/clinical study, and overall clinical development upon request.
Representative Directors	President & CEO Yoshiharu Sakashita
Directors	Toru Kino Masanori Oka (External Director)
Auditor	Mitsuhiro Katsuyama
Corporate Officer	Shinichi Sase Masayuki Katae Yasuhiro Takamatsu
Office	Osaka Head Office 1-15-2 Nishinakajima, Yodogawa-ku, Osaka 532-0011, Japan TEL: +81-6-6309-5200 FAX: +81-6-6309-5203 Tokyo Office 2-35-14 Nihonbashi Ningyocho, Chuo-ku, Tokyo 103-0013, Japan TEL: +81-3-5652-6000 FAX: +81-3-5652-6002
Investors	Total number of stock issued as of March 2010 is 32,256. Major investors are as follows: Daiwa SMBC Capital Mitsubishi UFJ Capital Co., Ltd. COLLABO SANGAKUKAN